Summary We previously reported that the anti-tumour effect of OK-432 is considerably enhanced by its intratumoral injection together with fibrinogen. In the present study, we generated killer T cells by culturing tumour-infiltrating lymphocytes from thyroid cancer patients who had received this local immunotherapy. Phenotypic analysis revealed that the T cells were positive for CD3+, CD4+, Leu8-, CD45RO+ and T-cell 
The streptococcal preparation OK-432 is an immunostimulator produced by treating the Su strain of Streptococcus pyogenes with heat and penicillin, and it has been recognised as one of the most effective biological response modifiers (BRMs) for augmenting host immunity Torisu et al., 1983; Uchida et al., 1984; Watanabe & Iwa, 1987; Haruna et al., 1990) . We have previously shown that the anti-tumour activity of OK-432 is considerably enhanced by intratumoral injection together with fibrinogen . This local immunotherapy effectively induces the marked infiltration of inflammatory cells into the tumour stroma on the day after injection and can contribute to tumour regression. We have also demonstrated that the regional lymph nodes of cancer patients receiving this local immunotherapy were a useful source of competent B lymphocytes for the establishment of human-human hybridomas (Baba et al., 1992; Yagyu et al., 1993) , and we have established cytotoxic CD4+ T-cell clones from such lymph nodes (Nagaoka et al., 1992) . In the present study, we generated cytotoxic CD4+ T cells from the tumour-infiltrating lymphocytes (TILs) of thyroid cancer patients who had received the intratumoral injection of OK-432 with fibrinogen.
CD4 and CD8 are cell-surface molecules that are expressed on mutually exclusive subsets of T lymphocytes. CD8+ T lymphocytes mediate cytotoxic activity against target cells that are recognised in an MHC class I-restricted fashion.
In contrast, the major function of CD4+ T cells, which recognise antigens that bind to MHC class II molecules, is to promote antibody production by B cells and the secretion of a number of biologically important cytokines. Several reports have documented that both CD4+ and CD8+ cells show cytolytic activity when activated by target cells bearing the appropriate antigen or by non-specific stimulants (Fleischer, 1984; Tite et al., 1985; Noguchi et al., 1989; Erb et al., 1990; Ju et al., 1990) . Cytolysis mediated by CD8+ T lymphocytes is now well documented, but as is the case for CD4+ cells, the mechanisms involved are still controversial (Nagaoka et al., 1992; Nishimura et al., 1992; Ozdemirli et al., 1992; Apasov et al., 1993) .
The adhesion molecules expressed on T lymphocytes are crucial for stabilising cell-cell interactions. They were first thought to be accessory molecules that simply joined one cell inger, 1990; Rothlein et al., 1986; Rothlein and Wegner, 1992) .
In this study, we analysed the characteristics and the killing mechanisms of cytotoxic CD4+ T lymphocytes generated by local immunotherapy, as well as the role of ICAM-1 expression of these T cells in the cytotoxic activity of these cells. Cytokine assay The generated CD4+ T lymphocytes (1 x 107) were cultured in AIM-V medium containing 1000 U ml-' of recombinant IL-2 and 0.05 KE ml-' of OK-432 in a total volume of 10 ml. After 48 h, the supernatants were used for the assay of cytokines.
Materials and methods

Local immunotherapy
In some experiments, CD4+ T cells were stimulated with immobilised monoclonal antibodies. A 96-well, flat-bottomed cell culture cluster dish (Costar, Cambridge, MA, USA) was coated with 10 tg ml-' of anti-ICAM-1, anti-LFA-1, or anti-CD3 monoclonal antibodies. Normal mouse serum containing 10 jg ml' of non-specific IgG was used as the negative control. After overnight incubation at 4°C, the excess antibodies were removed and the plates were washed twice with phosphate-buffered saline (PBS). Then the plates were used to stimulate CD4+ T lymphocytes by culturing the T cells (2 x I05 per well) in a total volume of 200 tl for 24 h at 37°C. Cell-free supernatants were harvested and stored at -20C until quantitation of the IFN-' content.
Cytokines were detected by the two-site sandwich enzymelinked immunosorbent assay (ELISA) technique using monoclonal antibodies to coat the solid phase and as the secondary antibody. The ELISA kits for IFN-y and IL-4 were obtained from Medgenix (Fleurus, Belgium), while that for IL-6 was from Toray Industries (Tokyo, Japan), that for TNF-a came from Otsuka Pharmaceutical (Tokyo, Japan), and that for TNF-P was from Bender Depl. MedSystems (Vienna, Austria). Samples were assayed in duplicate and quantitated by comparison with standard curves obtained using purified recombinant or natural cytokines.
Generation and analysis of cytotoxic CD4+ T lymphocytes Y Katsumoto et al 111 Germany) at various effector-target ratios, and were incubated for 3 h at 37°C.
As a negative control, medium without effector cells was added, and 0.2% Nonidet P-40 (Sigma) was used as the positive control. After incubation, 5 ,lI of clarified bovine haemoglobin (5 mM, Sigma) was added to diminish the background fluorescence released from lysed target cells. After measuring the fluorescence intensity of the surviving target cells with an MPV compact MT (Leitz, Wetzlar, Germany), the per cent lysis was calculated by the following formula:
Mean experimental reading - Conjugation between the CD4+ T cells and target cells was assessed as described previously with slight modifications (Martz, 1975; Ozdemirli et al., 1992 antibodies (2 .tg ml-') for I h at 37C. After washing twice in AIM-V to remove excess antibodies these effector cells were used for the cytotoxicity and conjugation assays as described above.
Results
We analysed TILs from seven thyroid cancer patients who received intratumoral injection of OK-432/fbg, as well as cells from four patients without immunotherapy. FACS analysis of TILs from the former patients showed increased surface expression of HLA-DR, CD25, and ICAM-1 when compared with cells from the latter patients (Figure 1 ). (Table I) . The in v,itro cytotoxicity assay showed that local immunotherapy considerably enhanced NK and lymphokine activated killer (LAK) activity of TILs (Figure 1 ). During culture, the cytolytic activity of TILs from the OK-432/fbg group was not reduced despite the expansion of CD4+ T cells, although TILs from the control group only showed cytolytic activity when CD8+-LAK cells were generated (Table I ). Figure 2 shows the representative phenotype of cytotoxic CD4+ T cells from seven patients after culture for more than 5 weeks. FACS analysis revealed that the proliferating T cells expressed the helper T phenotype (CD4+ and Leu8-). The majority of the T cells were positive for T cell receptor (TCR) 4xB, CD45RO and LFA-1, and the surface expression of HLA-DR, the IL-2 receptor (CD25), and ICAM-1 gradually increased throughout culture (Table I) .
To further characterise these CD4+ T cells, cytokine production in culture supernatants was measured by ELISA. CD4+ T cells stimulated with OK-432 produced high amounts of IFN-and TNF-Pf but no IL-4 was secreted by these T cells. Other cytokines, such as TNF-ca and IL-6, were also detected in the culture supernatants. The results are summarised in Table II. The cytotoxicity assay revealed that these T cells exhibited a high level of killing activity against a broad spectrum of target cells, including Daudi cells, K562 cells and allogenic thyroid cancer cell lines (NPA, KOA-2 and K-1 19), but did not kill autologous or allogenic peripheral blood lymphocytes (Figure 3 ). Once activated, the cytotoxic CD4+ T cells did not require OK-432 to express their cytotoxicity, because addition of OK-432 to the assay system at various concentrations did not alter the cytolysis of Daudi or K562 cells (data not shown).
This suggested that the killing activity of these CD4+ T cells was non-MHC-restricted and that their cytotoxic activity might be supported by other surface molecules such as adhesion molecules. To evaluate the role of such molecules in cytotoxicity we performed an inhibition assay. Cytotoxic activity and conjugation were examined as described in Materials and methods, and the percent inhibition was calculated. All experiments were performed in triplicate, and date from one representative experiment is presented. To further evaluate the role of the adhesion molecules, we performed a combined inhibition assay of cell conjugation and cytotoxicity using CD4+ killer T cells and Daudi cells. Anti-CD2 and anti-LFA-I monoclonal antibodies reduced cytotoxic activity by less than 15%, and the per cent inhibition of cell conjugation was similar. Interestingly, although anti-ICAM-l pretreatment of the effector CD4+ T cells inhibited their killing activity, it did not affect cell conjugation ( Figure 5) .
As anti-ICAM-l did not inhibit cytolytic activity by blocking cell-cell adhesion, it was suggested that ICAM-1 may have a signal transduction role in lymphocytes that promotes killing activity. Incubation with immobilised anti-CD3 monoclonal antibody considerably augmented IFN-y secretion by the cytotoxic CD4+ T cells. Interestingly, immobilised anti-ICAM-1 antibody also enhanced IFN-y secretion to about five times that seen with control IgG, although anti-LFA-1 did not (Table III) .
Discussion Both CD4+ and CD8+ T cells can express cytolytic activity against a variety of antigen-bearing target cells, and cytotoxic CD4+ T cells can be generated by activation with nonspecific stimulants. OK-432 is a non-specific immunopotentiator of bacterial origin that has been reported to induce cytotoxic CD4+ T cells in both mice and humans (Ozaki and Suginoshita, 1989; Ozaki et al., 1990; Nagaoka et al., 1992) . In the present study, we generated cytotoxic CD4+ T lymphocytes from the TILs of thyroid cancer patients treated with our augmented immunisation protocol using OK-432/ fbg . TILs were used because they are more effective and have a greater activity against tumour cells (Rosenberg et al., 1986; Topalian et al., 1987) .
Local immunotherapy with OK-432/fbg induces severe inflammation at the site of injection and in the draining lymph nodes (Sakita et al., 1993) . FACS analysis revealed the increased expression of HLA-DR, CD25 and ICAM-1 by TILs about 1 week after the injection of OK-432/fbg. These TILs also showed high levels of NK and LAK activity. Thus, our findings suggest that local immunotherapy both activated T cells that infiltrated the tumour stroma and enhanced the killing activity of these TILs.
We established cytotoxic CD4+ T cells by culturing TILs from patients injected with OK-432/fbg in medium containing recombinant IL-2 and performing repeated stimulation with OK-432. FACS analysis of the generated killer cells showed the helper T cell phenotype (negative for CD56, CD8 or Leu8, but positive for CD4). These T cells were also positive for HLA-DR, CD25, LFA-1 and ICAM-1, which are markers of activated lymphocytes. Furthermore, the generated CD4+ killer T cells were memory T cells (CD45RO+), not naive T cells (CD45RA+) and were positive for TCRaxp.
To further characterise these CD4+ T cells, cytokine levels in culture supernatants were measured by ELISA. These cells produced high amounts of IFN-y and TNF-P, as well as producing TNFE-and relatively low amounts of IL-6. However, there was no detectable IL-4 production. Recently, it has become apparent that in animal models as well as in humans, CD4+ helper T cells can be categorised into three main subpopulations based on their functional characteristics and cytokine production profiles (ThO, TH 1, and TH2) (Wierenga et al., 1991; Romagnani, 1991 effector-independent cell lysis (Ozdemirli et al., 1992; Apasov et al., 1993) . Thus, the inhibition of killing for Daudi cell by anti-ICAM-l was apparently not achieved by blocking cell-cell attachment, but by blocking some post-binding event.
It has recently become apparent that several of the molecules involved in leucocyte adhesion also serve as signalling molecules. LFA-1, ICAM-l, and LFA-3 provide signals that regulate the lytic ability of LAK and cytotoxic T lymphocytes (CTL) effectors, and antibodies to those molecules enhance the production of IFN-y, TNF-a or TNF-P when co-immobilised with anti-CD3 Ab (Chong et al., 1992; Galandrini et al., 1992) . The co-stimulatory effects of LFA-1, LFA-2, and CD45 on T cells are well documented (Denning et al., 1988; Marvel and Mayer, 1988; Moingeon et al., 1991; van Seventer et al., 1991) , but there have been few investigations of whether ICAM-1 can also transduce signals in ICAM-1 expressing killer T cells.
Our experiments show that incubation with an immobilised anti-CD3 antibody considerably augmented IFN-y secretion by the cytotoxic CD4+ T cells. An immobilised anti-ICAM-l antibody also enhanced IFN-y secretion, while immobilised anti-LFA-1 did not. Cross-linking of surface membrane receptors with monoclonal antibodies mimics natural receptor/ligand interactions and thus triggers the same cellular processes (Wachlotz et al., 1989; van Seventer et al., 1991) . Therefore, these data support the concept that ICAM-1 transmitted signals by interacting with a natural ligand to enhance cytokine production by the CD4+ T cells. Crosslinking of ICAM-1 on mononuclear leucocytes induces an oxidative burst (Rothlein et al., 1994) , indicating the existence of a signalling pathway mediated via this adhesion molecule.
As IFN-y is a potent regulator of the immune response, up-regulation of its production by ICAM-1 may contribute to T cell activation and cytotoxicity. In conclusion, our findings suggest that the cytolytic activity of CD4+ T cells generated by OK-432/fbg therapy may be supported by signal transduction through ICAM-1.
